Related Experiment Video
Updated: Mar 23, 2026

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
Published on: December 15, 2023
HIV, HBV and HCV Coinfection Prevalence in Iran--A Systematic Review and Meta-Analysis
Fahimeh Bagheri Amiri1,2, Ehsan Mostafavi1,3,4, Ali Mirzazadeh5,4
1Department of Epidemiology, Pasteur Institute of Iran, Tehran, Iran.
Insights
People who inject drugs (PWID) in Iran are disproportionately affected by HIV, hepatitis B (HBV), and hepatitis C (HCV) coinfections. Enhanced screening is crucial to prevent new infections and reduce transmission among this vulnerable population.
Area of Science:
- Infectious Diseases
- Public Health
- Epidemiology
Background:
- Hepatitis B (HBV) and hepatitis C (HCV) are common coinfections with human immunodeficiency virus (HIV), posing significant survival threats to HIV-infected individuals.
- Estimating the prevalence of these coinfections in Iran is critical for public health strategies.
Purpose of the Study:
- To estimate the prevalence of HIV, HBV, HCV, and their coinfections (HIV/HCV, HIV/HBV, and triple infections) in various subpopulations within Iran.
Main Methods:
- A systematic review and meta-analysis adhering to PRISMA guidelines was conducted.
- Literature from January 1996 to March 2012 was systematically searched in English and Persian/Farsi databases.
- Prevalence data for HIV, HBV, and HCV antibodies/antigens were extracted and reported with 95% confidence intervals.
Main Results:
- HIV prevalence ranged from 0% in the general population to 17.25% in people who inject drugs (PWID).
- HBV prevalence was highest in PWID (30.9%), and HCV prevalence was also highest in PWID (51.46%).
- Coinfections were zero in the general population and healthcare workers, but common in PWID: HIV/HCV (10.95%), HIV/HBV (1.88%), and triple infections (1.25%).
Conclusions:
- People who inject drugs (PWID) are severely and disproportionately impacted by HIV, HBV, and HCV coinfections in Iran.
- Reinforcing screening for these coinfections is essential for prevention and reducing transmission within this community and to others.
Background:
worldwide, hepatitis C and B virus infections (HCV and HCV), are the two most common coinfections with human immunodeficiency virus (HIV) and has become a major threat to the survival of HIV-infected persons. The review aimed to estimate the prevalence of HIV, HBV, HCV, HIV/HCV and HIV/HBV and triple coinfections in different subpopulations in Iran.
Method:
Following PRISMA guidelines, we conducted a systematic review and meta-analysis of reports on prevalence of HIV, HBV, HCV and HIV coinfections in different subpopulations in Iran. We systematically reviewed the literature to identify eligible studies from January 1996 to March 2012 in English or Persian/Farsi databases. We extracted the prevalence of HIV antibodies (diagnosed by Elisa confirmed with Western Blot test), HCV antibodies and HBsAg (with confirmatory laboratory test) as the main primary outcome. We reported the prevalence of the three infections and coinfections as point and 95% confidence intervals.
Findings:
HIV prevalence varied from %0.00 (95% CI: 0.00-0.003) in the general population to %17.25 (95% CI: 2.94-31.57) in people who inject drugs (PWID). HBV prevalence ranged from % 0.00 (95% CI: 0.00-7.87) in health care workers to % 30.9 (95% CI: 27.88-33.92) in PWID. HCV prevalence ranged from %0.19 (95% CI: 0.00-0.66) in health care workers to %51.46 (95% CI: 34.30-68.62) in PWID. The coinfection of HIV/HBV and also HIV/HCV in the general population and in health care workers was zero, while the most common coinfections were HIV/HCV (10.95%), HIV/HBV (1.88%) and triple infections (1.25%) in PWID.
Conclusions:
We found that PWID are severely and disproportionately affected by HIV and the other two infections, HCV and HBV. Screenings of such coinfections need to be reinforced to prevent new infections and also reduce further transmission in their community and to others.
Related Concept Videos
Hepatitis
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Retrovirus Life Cycles
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Infectious Diseases and Their Occurrence
Cytomegalovirus Disease

